A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Intervention Called Sisunatovir in Healthy Adults
This study aims to understand how a medicine that lowers stomach acid might affect levels of a new drug called Sisunatovir in the blood. Sisunatovir is being developed to treat RSV, a common breathing infection. By giving healthy adult volunteers both Sisunatovir and a stomach acid-reducing medicine, researchers can see if one affects the other. This information is important because it helps doctors know if people taking stomach acid medications can also safely take Sisunatovir, and if any dose adjustments might be needed. The study is a first step (Phase 1) to ensure the new medicine works as intended and is safe when taken with other common drugs.
At a glance
What is this study about?
This research study is looking into a new medicine called Sisunatovir. Sisunatovir is being developed to help people who have a breathing infection called RSV. RSV is very common, especially in young children and older adults, and can sometimes cause serious health problems. Before any new medicine can be used widely, scientists need to understand everything about it, including how it interacts with other common medicines people might be taking.
In this particular study, we want to see what happens when someone takes Sisunatovir at the same time as a medicine that reduces stomach acid. Many people take medicines to reduce stomach acid for conditions like heartburn or indigestion. We need to find out if taking these two types of medicines together changes how much Sisunatovir gets into a person's bloodstream. This is important because the amount of medicine in the blood can affect how well it works and if it causes any side effects.
The study involves healthy adult volunteers. This means people who generally don't have any major health problems. By studying healthy people first, researchers can get a clear picture of how the medicine behaves without other illnesses complicating the results. The aim is to make sure that when Sisunatovir is eventually used to treat RSV, doctors will know the best and safest way for patients to take it, even if they are also on other medications.
Key takeaways
- This study is testing a new medicine (Sisunatovir) for an infection called RSV.
- It's looking at how a common stomach acid-reducing drug might affect Sisunatovir levels in the body.
- Healthy adults (18 years and older) are needed for this research.
- Participation involves clinic visits, taking study medicines, and having blood tests.
- The goal is to ensure the new medicine is safe and effective when used with common medications.
Who may be eligible?
To join this study, you need to be a healthy adult, 18 years old or older. The study is open to both men and women.
Being 'healthy' usually means you don't have any serious ongoing medical conditions, you're not taking certain medications, and your organs are working well. The research team will do medical checks to make sure you fit this description.
If you have complicated health issues or are taking many other medications, this study might not be suitable for you, as the researchers need to clearly see how the study medicine works without other factors getting in the way.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally healthy with no major ongoing medical conditions?
- Are you comfortable visiting a clinic regularly for appointments?
- Are you willing to take study medicines and have blood tests?
- Are you able to understand and follow study instructions?
What does participation involve?
If you decide to take part, you will be given Sisunatovir and a medicine that reduces stomach acid. You will have several visits to the study clinic where doctors and nurses will monitor your health closely. This will involve having regular blood tests to measure the levels of Sisunatovir in your body. You might also have other checks, such as measuring your blood pressure and heart rate. The study will last for a specific period, and the research team will explain all the appointments and what each one involves. You'll be told about the total duration of your participation, including any follow-up visits.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What is RSV?
RSV stands for Respiratory Syncytial Virus. It's a common virus that can cause cold-like symptoms, but it can be more serious for babies, young children, and older adults, sometimes leading to breathing difficulties.
What is Sisunatovir?
Sisunatovir is a new medicine that researchers are developing to treat RSV. This study is one of the first steps to understand how it works in people.
Why use healthy adults for this study?
Using healthy adults helps researchers understand how the medicine behaves in the body without other health problems complicating the results. This is a common and important first step in testing new medicines.
Will I get money for taking part?
Compensation for your time and travel expenses is often provided in clinical studies. The study team will be able to give you specific details about this.
How long will I be in the study?
The total length of time you'd be involved, including all visits, will be explained by the study team. Early studies like this usually have a defined duration.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.